Profile data is unavailable for this security.
About the company
PetVivo Holdings, Inc. is a biomedical device company. The Company is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Company’s lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The Company is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a body’s cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The Company has a pipeline of therapeutic devices for both veterinary and human clinical applications.
- Revenue in USD (TTM)1.05m
- Net income in USD-10.63m
- Incorporated2009
- Employees25.00
- LocationPetVivo Holdings Inc5251 Edina Industrial BlvdEDINA 55439United StatesUSA
- Phone+1 (952) 217-4952
- Fax+1 (775) 884-9383
- Websitehttps://petvivo.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BioSig Technologies Inc | 27.00k | -25.25m | 6.35m | 4.00 | -- | -- | -- | 235.32 | -3.24 | -3.24 | 0.0033 | -0.3776 | 0.008 | -- | 1.74 | 6,750.00 | -728.65 | -269.73 | -- | -363.11 | 48.15 | -- | -91,566.66 | -24,485.73 | -- | -- | -- | -- | -93.71 | -- | -6.52 | -- | -9.58 | -- |
Sigyn Therapeutics Inc | 0.00 | -3.56m | 6.43m | 5.00 | -- | -- | -- | -- | -3.04 | -3.04 | 0.00 | -3.28 | 0.00 | -- | -- | 0.00 | -724.37 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0199 | -1.92 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
Sonendo Inc | 40.19m | -57.74m | 6.69m | 216.00 | -- | 0.2725 | -- | 0.1664 | -0.6125 | -0.5552 | 0.426 | 0.3482 | 0.4448 | 2.07 | 7.58 | 186,055.60 | -63.91 | -- | -78.82 | -- | 27.64 | -- | -143.67 | -- | 2.14 | -10.83 | 0.4695 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
Nexalin Technology Inc | 158.86k | -4.94m | 6.69m | 6.00 | -- | 2.87 | -- | 42.09 | -0.6676 | -0.6676 | 0.0215 | 0.3129 | 0.0363 | 0.1778 | 44.01 | 26,476.67 | -112.76 | -- | -139.94 | -- | 82.54 | -- | -3,110.58 | -- | 4.75 | -- | 0.00 | -- | -91.62 | -- | -173.80 | -- | -- | -- |
Vivos Therapeutics Inc | 13.36m | -15.64m | 7.26m | 114.00 | -- | 10.56 | -- | 0.5434 | -11.00 | -11.00 | 8.73 | 0.2131 | 0.9247 | -- | 31.59 | 117,219.30 | -108.24 | -89.72 | -243.30 | -149.70 | 58.90 | 70.20 | -117.06 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
Neurometrix Inc | 5.27m | -7.98m | 7.42m | 26.00 | -- | 0.3909 | -- | 1.41 | -6.32 | -6.32 | 4.20 | 9.44 | 0.2381 | 1.25 | 10.08 | 202,700.40 | -36.07 | -23.24 | -38.94 | -27.26 | 61.97 | 59.17 | -151.51 | -48.88 | 10.11 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
Guided Therapeutics Inc | 82.00k | -3.23m | 7.80m | 4.00 | -- | -- | -- | 95.07 | -0.0623 | -0.0623 | 0.0016 | -0.0721 | 0.0374 | 0.0904 | 11.71 | 20,500.00 | -137.80 | -136.13 | -- | -- | 32.93 | 29.39 | -3,685.37 | -3,666.67 | 0.1138 | -11.13 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
ALR Technologies Inc | 9.49k | -8.00m | 9.53m | 6.00 | -- | -- | -- | 1,004.43 | -0.0147 | -0.0147 | 0.00002 | -0.0476 | 0.0358 | -- | -- | 1,581.67 | -3,015.28 | -12,861.64 | -- | -- | 62.49 | -- | -84,283.24 | -406,011.30 | -- | -0.8626 | -- | -- | -- | -- | -42.72 | -- | -- | -- |
Biomerica Inc | 5.41m | -6.35m | 9.71m | 62.00 | -- | 1.24 | -- | 1.80 | -0.3789 | -0.3789 | 0.3224 | 0.4642 | 0.5827 | 2.28 | 5.74 | 87,180.80 | -68.45 | -43.55 | -83.73 | -50.32 | 11.41 | 15.75 | -117.46 | -55.86 | 3.37 | -- | 0.00 | -- | -71.71 | -0.8229 | -57.58 | -- | -9.76 | -- |
Innovative Eyewear Inc | 1.39m | -7.20m | 9.84m | 11.00 | -- | 1.42 | -- | 7.07 | -0.6074 | -0.6074 | 0.1174 | 0.2948 | 0.2803 | 1.89 | 15.42 | 126,457.30 | -145.15 | -- | -168.75 | -- | -8.82 | -- | -517.88 | -- | 3.68 | -6,764.71 | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
Biotricity Inc | 11.63m | -15.39m | 9.93m | 55.00 | -- | -- | -- | 0.8536 | -1.75 | -1.75 | 1.32 | -2.84 | 1.92 | 2.01 | 6.55 | 211,408.70 | -240.40 | -303.46 | -- | -- | 65.52 | 53.00 | -125.43 | -368.78 | 0.1012 | -0.5855 | -- | -- | 26.00 | -- | 35.36 | -- | -- | -- |
PetVivo Holdings Inc | 1.05m | -10.63m | 9.95m | 25.00 | -- | 9.73 | -- | 9.52 | -0.8694 | -0.8694 | 0.0842 | 0.06 | 0.3375 | 1.21 | 2.04 | 41,841.60 | -343.12 | -209.90 | -715.73 | -504.64 | 51.41 | 20.27 | -1,016.55 | -2,297.21 | 0.6169 | -2,268.84 | 0.1392 | -- | 693.46 | 260.32 | -73.83 | -- | 51.73 | -- |
PAVmed Inc | 3.02m | -71.05m | 10.00m | 107.00 | -- | -- | -- | 3.31 | -9.08 | -9.08 | 0.3874 | -7.76 | 0.0588 | -- | 64.17 | 28,186.92 | -147.38 | -154.56 | -- | -1,152.82 | -126.09 | -- | -2,505.37 | -8,764.89 | 0.5301 | -8.32 | 1.82 | -- | 550.40 | -- | 25.76 | -- | 55.51 | -- |
Bionoid Pharma Inc | 0.00 | 1.35m | 10.80m | 13.00 | 0.1764 | -- | 7.98 | -- | 1.13 | 1.13 | 0.00 | -0.1744 | -- | -- | -- | -- | -- | -506.64 | -- | -- | -- | -- | -- | -- | -- | 327.24 | -- | -- | -- | -- | -31.55 | -- | 26.01 | -- |
STRATA Skin Sciences Inc | 32.55m | -11.36m | 10.87m | 99.00 | -- | 1.15 | -- | 0.334 | -3.25 | -3.25 | 9.31 | 2.69 | 0.73 | 3.67 | 8.60 | 328,737.40 | -25.49 | -11.48 | -35.77 | -16.55 | 52.71 | 61.28 | -34.91 | -17.70 | 0.8376 | -3.90 | 0.6151 | -- | -7.75 | 2.24 | -95.17 | -- | 23.29 | -- |
SeaStar Medical Holding Corp | 0.00 | -33.67m | 11.61m | 12.00 | -- | -- | -- | -- | -26.64 | -26.64 | 0.00 | -1.48 | 0.00 | -- | -- | 0.00 | -605.20 | -- | -- | -- | -- | -- | -- | -- | -- | -4.39 | -- | -- | -- | -- | -115.19 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Bard Associates, Inc.as of 31 Mar 2024 | 418.80k | 2.46% |
Regal Investment Advisors LLCas of 31 Mar 2024 | 19.00k | 0.11% |
Asset Dedication LLCas of 31 Mar 2024 | 14.57k | 0.09% |
Boothbay Fund Management LLCas of 31 Mar 2024 | 13.89k | 0.08% |
Cetera Investment Advisers LLCas of 31 Mar 2024 | 10.00k | 0.06% |
Tower Research Capital LLCas of 31 Mar 2024 | 5.32k | 0.03% |
Bank of America, NA (Private Banking)as of 31 Mar 2024 | 1.00k | 0.01% |
Delos Wealth Advisors LLCas of 31 Mar 2024 | 5.00 | 0.00% |
Koshinski Asset Management, Inc.as of 31 Mar 2024 | 0.00 | 0.00% |
HRT Financial LLCas of 31 Mar 2024 | 0.00 | 0.00% |